Invention Grant
- Patent Title: Triazine derivatives for treating diseases relating to neurotrophins
-
Application No.: US16975437Application Date: 2019-02-26
-
Publication No.: US11352332B2Publication Date: 2022-06-07
- Inventor: Gunnar Nordvall
- Applicant: AlzeCure Pharma AB
- Applicant Address: SE Huddinge
- Assignee: AlzeCure Pharma AB
- Current Assignee: AlzeCure Pharma AB
- Current Assignee Address: SE Huddinge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Mei Bai
- Priority: SE1850217-9 20180226,GB1810667 20180628
- International Application: PCT/GB2019/050523 WO 20190226
- International Announcement: WO2019/162702 WO 20190822
- Main IPC: C07D251/30
- IPC: C07D251/30 ; A61K31/53 ; C07D401/04 ; C07D403/10 ; C07D405/12 ; C07D409/04 ; C07D413/10 ; C07D417/04
Abstract:
There is provided herein a compound of formula (I) wherein R1, R2, n, X, Q, L, m, R3 and p are as defined herein, which compounds are useful in the treatment of treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like.
Public/Granted literature
- US2288857A Process for the removal of bitumen from bituminous deposits Public/Granted day:1942-07-07
Information query
